Scholars Central

ArticlePublished 2013

Blood glucose and lipids profile in non-diabetic patients taking propranolol.

Authors: Mohammad Ayatollahi, Golrasteh Kholasehzadeh

Biomedical Research

Volume 24 · Issue 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This study investigated the effects of propranolol (P) as a non-selective b-adrenergic receptor blocker on blood glucose and lipid profile in non-diabetic patients. The results of this project will be a guide to prevent occurrence of hypoglycemic signs (tachycardia, palpitation, feeling hunger, blood pressure changes, anxiety and sweating) and its undesired consequences in P takers. Thirty seven patients chosen were without any serious cardiovascular complications and also without hearing, intellectual and visual defects. Fasting blood glucose and lipid profile of the patients were estimated by autoanalyser instrument, BT3000. Only comparison between blood HDL level before taking P and after an 8-week period of taking P became significant (Pv = 0.034) and the variable mentioned showed a reduction of level in most of the P takers. It is concluded that if a patient needs a beta adrenergic blocker, a selective beta 1 blocker should be considered cautiously.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Mohammad Ayatollahi”
  • BylineArticles whose byline prints “Golrasteh Kholasehzadeh”